Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the therapeutic efficacy of interferon alfa 2b and
topical mitomycin C in patients with diagnosis of conjunctival-corneal intraepithelial
neoplasia.
Phase:
Phase 4
Details
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Collaborators:
Instituto Mexicano del Seguro Social University of Guadalajara